Skip to content

The value of hybrid transanal-laparoscopic total mesorectal excision in Sphincter-preserving Surgery for low rectal carcinoma

The value of hybrid transanal-laparoscopic total mesorectal excision in Sphincter-preserving Surgery for low rectal carcinoma

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17012158
Enrollment
Unknown
Registered
2017-07-27
Start date
2017-08-01
Completion date
Unknown
Last updated
2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rectal carcinoma

Interventions

intervention group: hybrid transanal-laparoscopic total mesorectal excision

Sponsors

Nanchong Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. According to NCCN rectal cancer diagnosis and treatment guidelines,no anti_tumor treatment(cT1-2N0M0)or standard neoadjuvant chemoradiotherapy was applied before the clinical trial; 2. Aged between 18 and 80 years old; 3. rectal carcinoma was pathologically diagnosed; 4. Tumor position:3cm-10cm from the dentate line; 5. preoperative MRI evaluation: T1-T3, N0-N1, M0, feasible for standard laparoscopic TME Dixon operation; 5. ECOG score 0-1.

Exclusion criteria

Exclusion criteria: 1. 5 years history of other malignant tumors; 2. Multiple colorectal cancer or other malignant tumors; 3. Distant metastases(M1); 4. Preoperative rectal cancer with intestinal obstruction or a history of colorectal surgery; 5. Serious or uncontrol mental illness; 6. Long-term use of hormone or immunosuppressants; 7. Abuse of drugs and medical, psychological or social conditions may interfere the results of assessment.

Design outcomes

Primary

MeasureTime frame
Diease free survial;

Secondary

MeasureTime frame
Overall survial;operating time;anal function;postoperative morbidity;

Contacts

Public ContactRen Mingyang

Nanchong Central Hospital

2861746489@qq.com+86 13890756658

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026